A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density

A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density

Item
http://www.wikidata.org/entity/Q27308658
Molecular imaging of integrin αvβ6 expression in living subjects.Active targeted drug delivery for microbes using nano-carriersThe impact of nanoparticle protein corona on cytotoxicity, immunotoxicity and target drug deliveryModular Three-component Delivery System Facilitates HLA Class I Antigen Presentation and CD8(+) T-cell Activation Against Tumors.Hyaluronan polymer length, grafting density, and surface poly(ethylene glycol) coating influence in vivo circulation and tumor targeting of hyaluronan-grafted liposomes.Identification of a novel lysosomal trafficking peptide using phage display biopanning coupled with endocytic selection pressureCombinatorial synthesis and screening of cancer cell-specific nanomedicines targeted via phage fusion proteins.Uptake of ferromagnetic carbon-encapsulated metal nanoparticles in endothelial cells: influence of shear stress and endothelial activation.The Effect of Bi-Terminal PEGylation of an Integrin αvβ₆-Targeted ¹⁸F Peptide on Pharmacokinetics and Tumor Uptake.Role of microRNA-4458 in patients with non-small-cell lung cancerLung cancer nanomedicine: potentials and pitfalls.Paradigm shift in bacteriophage-mediated delivery of anticancer drugs: from targeted 'magic bullets' to self-navigated 'magic missiles'.Investigating in vitro and in vivo αvβ6 integrin receptor-targeting liposomal alendronate for combinatory γδ T cell immunotherapy.Nanoscale Ultrasound-Switchable FRET-Based Liposomes for Near-Infrared Fluorescence Imaging in Optically Turbid Media.Non-Covalent Assembly Method that Simultaneously Endows a Liposome Surface with Targeting Ligands, Protective PEG Chains, and Deep-Red Fluorescence Reporter Groups.PNC27 anticancer peptide as targeting ligand significantly improved antitumor efficacy of Doxil in HDM2-expressing cells.Application of active targeting nanoparticle delivery system for chemotherapeutic drugs and traditional/herbal medicines in cancer therapy: a systematic review
P2860

A liposomal drug platform overrides peptide ligand targeting to a cancer biomarker, irrespective of ligand affinity or density

Item
http://www.wikidata.org/entity/Q27308658
description
2013 nî lūn-bûn
@nan
2013 թուականին հրատարակուած գիտական յօդուած
@hyw
2013 թվականին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
A liposomal drug platform over ...... of ligand affinity or density
@ast
A liposomal drug platform over ...... of ligand affinity or density
@en
A liposomal drug platform over ...... of ligand affinity or density
@nl
type
label
A liposomal drug platform over ...... of ligand affinity or density
@ast
A liposomal drug platform over ...... of ligand affinity or density
@en
A liposomal drug platform over ...... of ligand affinity or density
@nl
prefLabel
A liposomal drug platform over ...... of ligand affinity or density
@ast
A liposomal drug platform over ...... of ligand affinity or density
@en
A liposomal drug platform over ...... of ligand affinity or density
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P932
P356
P1433
P1476
A liposomal drug platform over ...... of ligand affinity or density
@en
P2093
P2860
P304
P31
P356
10.1371/JOURNAL.PONE.0072938
P407
P433
P478
P577
P5875
P698
P921
P932